Not applicableUnknownNCT05791890What this trial is testingGilteRInf 2022 Study (Gilteritinib Related Infections)Who this might be right forAcute Myeloid Leukemia University of Rome Tor Vergata 78
Early research (Phase 1)Ended earlyNCT02319369What this trial is testingSafety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)Who this might be right forAcute Myelogenous LeukemiaMyelodysplastic Syndrome Daiichi Sankyo 74
Early research (Phase 1)UnknownNCT05982756What this trial is testingBortezomib Combined With DAG Regimen in the Treatment of Refractory/Relapsed AMLWho this might be right forBortezomibAcute Myeloid Leukemia Zhongnan Hospital 40
Early research (Phase 1)UnknownNCT05467254What this trial is testingEvaluate the Safety and Efficacy of CLL1+CD33 CAR-T in Patients With R/R AMLWho this might be right forAML Zhejiang University 20
Early research (Phase 1)WithdrawnNCT04094766What this trial is testingSafety and Efficacy of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy in R/R Acute B Lymphoblastic LeukemiaWho this might be right forRefractory B Acute Lymphoblastic LeukemiaRelapse B Acute Lymphoblastic Leukemia Second Affiliated Hospital of Xi'an Jiaotong University
Not applicableNot Yet RecruitingNCT06902025What this trial is testingJY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell LeukemiaWho this might be right forB-ALL He Huang 24
Testing effectiveness (Phase 2)Study completedNCT01466179What this trial is testingClinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)Who this might be right forAcute Lymphoblastic Leukemia Amgen Research (Munich) GmbH 225
Post-approval studies (Phase 4)Study completedNCT03677596What this trial is testingTwo Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible PatientsWho this might be right forLeukemiaPrecursor b-Cell Lymphoblastic Leukemia-LymphomaACUTE LYMPHOBLASTIC LEUKEMIA Pfizer 102
Early research (Phase 1)Ended earlyNCT01455025What this trial is testingStudy in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia French Innovative Leukemia Organisation 11
Early research (Phase 1)Study completedNCT00470197What this trial is testingFlavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute LeukemiaWho this might be right forAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+13 more National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT00588991What this trial is testingVeliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative DisordersWho this might be right forAdult Acute Megakaryoblastic LeukemiaAdult Acute Monoblastic LeukemiaAdult Acute Monocytic Leukemia+20 more National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Ended earlyNCT00941928What this trial is testingHaploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL)Who this might be right forLeukemiaPediatric Cancer M.D. Anderson Cancer Center 2
Not applicableLooking for participantsNCT06649253What this trial is testingChildhood B-acute Lymphoblastic Leukaemia and Role of CD9 Gene Regulation in RelapseWho this might be right forLeukemia, Lymphoblastic, Acute, Pediatric Rennes University Hospital 50
Early research (Phase 1)Looking for participantsNCT05679895What this trial is testingSafety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LLWho this might be right forT-cell Acute Lymphoblastic LeukemiaLymphoblastic T-Cell Lymphoma OneChain Immunotherapeutics 20
Not applicableStudy completedNCT00281801What this trial is testingCaregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow TransplantationWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Case Comprehensive Cancer Center 168
Post-approval studies (Phase 4)Study completedNCT00488709What this trial is testingFludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia PETHEMA Foundation 47
Testing effectiveness (Phase 2)Study completedNCT00003619What this trial is testingCombination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic LeukemiaWho this might be right forChronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more Drexel University College of Medicine
Testing effectiveness (Phase 2)Study completedNCT01252667What this trial is testingClofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell TransplantWho this might be right forAcute Myeloid Leukemia Fred Hutchinson Cancer Center 44
Early research (Phase 1)Study completedNCT00624936What this trial is testingAzacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromesWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms Ohio State University Comprehensive Cancer Center 23
Early research (Phase 1)Study completedNCT01231919What this trial is testingMK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more National Cancer Institute (NCI) 45